INTEGRA LIFESCIENCES HOLDINGS CORP Deferred Revenue Recognized
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Deferred Revenue Recognized of -$7.31 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-07-29
- INTEGRA LIFESCIENCES HOLDINGS CORP contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was -$4.07M.
- INTEGRA LIFESCIENCES HOLDINGS CORP contract with customer, liability, revenue recognized for the quarter ending 2024-03-31 was -$2.02M.
- INTEGRA LIFESCIENCES HOLDINGS CORP contract with customer, liability, revenue recognized for the quarter ending 2023-03-31 was -$2.92M.
- INTEGRA LIFESCIENCES HOLDINGS CORP contract with customer, liability, revenue recognized for the quarter ending 2022-03-31 was -$1.98M, a 218.13% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP contract with customer, liability, revenue recognized for fiscal 2025 was -$10.15M.
- INTEGRA LIFESCIENCES HOLDINGS CORP contract with customer, liability, revenue recognized for fiscal 2024 was -$10.31M, a 250.82% decline from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP contract with customer, liability, revenue recognized for fiscal 2023 was $6.83M, a 27.76% increase from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP contract with customer, liability, revenue recognized for fiscal 2022 was $5.35M, a 3.58% increase from fiscal 2021.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$7.31M 10-Q · filed 2026-07-29 | |||
| 2026-03-31 | -$4.07M 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | -$10.15M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | -$10.31M 10-K · filed 2025-02-25 | |||
| 2024-09-30 | $4.45M 10-Q · filed 2024-11-04 | |||
| 2024-06-30 | -$7.52M 10-Q · filed 2024-07-29 | |||
| 2024-03-31 | -$2.02M 10-Q · filed 2024-05-06 | |||
| 2023-12-31 | $6.83M 10-K · filed 2024-02-28 | |||
| 2023-09-30 | -$6.28M 10-Q · filed 2023-10-25 | |||
| 2023-06-30 | -$6.17M 10-Q · filed 2023-07-27 | |||
| 2023-03-31 | -$2.92M 10-Q · filed 2023-04-26 | |||
| 2022-12-31 | $5.35M 10-K · filed 2023-02-22 | |||
| 2022-09-30 | $6.05M 10-Q · filed 2022-10-26 | |||
| 2022-06-30 | $3.59M 10-Q · filed 2022-07-27 | |||
| 2022-03-31 | -$1.98M 10-Q · filed 2022-04-27 | |||
| 2021-12-31 | $5.16M 10-K · filed 2022-02-24 | |||
| 2021-09-30 | -$3.69M 10-Q · filed 2021-11-02 | |||
| 2021-06-30 | $2.84M 10-Q · filed 2021-07-29 | |||
| 2021-03-31 | $1.68M 10-Q · filed 2021-04-29 | |||
| 2020-12-31 | $3.92M 10-K · filed 2021-02-23 | |||
| 2020-09-30 | $3.15M 10-Q · filed 2020-10-29 | |||
| 2020-06-30 | $2.28M 10-Q · filed 2020-08-10 | |||
| 2020-03-31 | $1.29M 10-Q · filed 2020-05-07 | |||
| 2019-12-31 | $5.61M 10-K · filed 2020-02-21 | |||
| 2019-09-30 | $6.34M 10-Q · filed 2019-10-25 | |||
| 2019-06-30 | $3.67M 10-Q · filed 2019-07-25 | |||
| 2019-03-31 | $1.17M 10-Q · filed 2019-04-29 | |||
| 2018-12-31 | $3.08M 10-K · filed 2019-02-26 | |||
| 2018-09-30 | $4.36M 10-Q · filed 2018-11-01 | |||
| 2018-06-30 | $2.69M 10-Q · filed 2018-07-26 | |||
| 2018-03-31 | $1.75M 10-Q · filed 2018-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |